Evidence map›Paper›PMID 41897908›Full record

ArticleAnimals : an open access journal from MDPI2026

Safety, Immunogenicity, and Vaccine Compatibility of a Trivalent Inactivated In Ovo Nanovaccine Against Avian Colibacillosis in Broilers Under Commercial Hatchery Conditions.

Angelo Scuotto, Daniela Ogonczyk-Makowska, Romain Magnez, Bryan Thiroux, Pierre-Louis Herrouin, Thomas Bouillet, Anaïs-Camille Vreulx, Amélie Degraeve, Didier Betbeder

Abstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angelo ScuottoVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Daniela Ogonczyk-MakowskaVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.ORCID 0000-0001-8178-4879
Romain MagnezVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Bryan ThirouxVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Pierre-Louis HerrouinVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Thomas BouilletVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Anaïs-Camille VreulxVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Amélie DegraeveVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.
Didier BetbederVaxinano SAS, 84 Rue du Dr. Yersin, 59120 Loos, France.

Funding

Innovative Veterinary Solutions for Antimicrobial Resistance. (InnoVet AMR) 109052-003
6 · The paper itself

Abstract

Avian colibacillosis, caused by

Indexed as

broilercolibacillosisE. coliinactivated vaccinein ovonanoparticle

Identifiers

PMID41897908
PMCPMC13023285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.